Suruchi Shrestha

Transglutaminase 2 Maintains Hepatocyte Growth Factor Signaling to Enhance the Cancer Cell Phenotype

R. Eckert, Wen Xu, Xi Chen, 2021, Molecular Cancer Research.

VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype

R. Eckert, Wen Xu, G. Adhikary, 2021, Molecular carcinogenesis.

ACTL6A suppresses p21Cip1 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype

R. Eckert, J. Friedberg, Wen Xu, 2021, Oncogenesis.

ACTL6A suppresses p21Cip1 expression to enhance the epidermal squamous cell carcinoma phenotype

R. Eckert, Wen Xu, G. Adhikary, 2020, Oncogene.

Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype

Xi Chen, R. Eckert, J. Friedberg, 2022, Molecular carcinogenesis.

Idiopathic retroperitoneal cyst in an adult male

Sanjay Sharma, Suruchi Shrestha, A. Jha, 2017, Urology annals.

Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial.

E. Stone, B. Tucker, R. Mullins, 2015, Translational research : the journal of laboratory and clinical medicine.

Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation

R. Eckert, J. Friedberg, A. Emadi, 2022, Molecular carcinogenesis.